NCT02724046View on ClinicalTrials.gov

Ciprofloxacin for the Prevention of Meningococcal Meningitis

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 22, 2017

Primary Completion Date

May 30, 2017

Study Completion Date

June 12, 2017

Conditions
Meningitis, Meningococcal
Interventions
DRUG

Ciprofloxacin

Single-dose oral ciprofloxacin

Trial Locations (1)

Unknown

Madarounfa Health District, Madarounfa

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Medecins Sans Frontieres, Netherlands

OTHER

lead

Epicentre

OTHER